Biotech | May 09, 2022
SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
Survey findings released in advance of World Lupus Day on May 10
The increase in PAT is driven by higher sales and lower marketing and depreciation charge vs the same period last year
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Subscribe To Our Newsletter & Stay Updated
